Nov-07-24 06:00AM
|
|
Oct-31-24 05:59AM
|
|
Oct-28-24 06:00AM
|
|
Oct-24-24 03:03AM
|
|
02:00AM
|
(Thomson Reuters StreetEvents) |
04:49PM |
Loading… |
Oct-23-24 04:49PM
|
|
07:10AM
|
|
06:10AM
|
(Associated Press Finance) |
06:09AM
|
|
06:00AM
|
|
Oct-22-24 05:00PM
|
|
03:01AM
|
|
Oct-20-24 07:00AM
|
|
Oct-16-24 02:00PM
|
|
Oct-15-24 09:15AM
|
|
07:51AM |
Loading… |
Oct-14-24 07:51AM
|
|
06:00AM
|
|
Oct-11-24 12:00PM
|
|
Oct-01-24 12:45PM
|
|
04:29AM
|
|
Sep-30-24 06:00AM
|
|
Sep-24-24 01:06PM
|
|
06:00AM
|
|
Sep-19-24 04:15PM
|
|
Sep-18-24 06:00AM
|
|
Sep-16-24 06:00AM
|
|
Sep-12-24 06:00AM
|
|
Sep-10-24 06:00AM
|
|
Sep-09-24 06:00AM
|
|
Sep-06-24 09:50AM
|
|
06:00AM |
Loading… |
Sep-05-24 06:00AM
|
|
Sep-03-24 06:00AM
|
|
Aug-21-24 01:46PM
|
|
Aug-20-24 06:00AM
|
|
Aug-19-24 06:00AM
|
|
Aug-16-24 03:55AM
|
|
Aug-15-24 11:34AM
|
|
07:02AM
|
|
Aug-12-24 04:30PM
|
|
Aug-06-24 06:00AM
|
|
Aug-05-24 06:00AM
|
|
Aug-02-24 09:50AM
|
|
Jul-29-24 06:00AM
|
|
Jul-25-24 01:56AM
|
(Thomson Reuters StreetEvents) |
Jul-24-24 01:50PM
|
|
09:30AM
|
|
07:10AM
|
|
06:16AM
|
|
06:09AM
|
(Associated Press Finance) |
06:00AM
|
|
Jul-23-24 03:09AM
|
|
Jul-22-24 06:00AM
|
|
Jul-18-24 06:00AM
|
|
Jul-17-24 10:00AM
|
|
Jul-16-24 12:10PM
|
|
09:50AM
|
|
06:00AM
|
|
06:00AM
|
|
Jul-11-24 06:00AM
|
|
Jul-10-24 10:07AM
|
|
Jul-08-24 03:46AM
|
|
Jul-01-24 06:00AM
|
|
Jun-28-24 09:55AM
|
|
Jun-27-24 06:00AM
|
|
Jun-18-24 06:00AM
|
|
Jun-06-24 06:00AM
|
|
May-30-24 11:31AM
|
|
May-23-24 06:00AM
|
|
May-22-24 06:00AM
|
|
May-16-24 02:20PM
|
|
09:04AM
|
|
May-13-24 06:00AM
|
|
May-09-24 02:15PM
|
|
May-08-24 04:15PM
|
|
May-06-24 06:00AM
|
|
May-02-24 09:50AM
|
|
08:23AM
|
(Pharmaceutical Business Review) |
06:00AM
|
|
May-01-24 09:03AM
|
|
02:10AM
|
|
Apr-30-24 10:33PM
|
(Thomson Reuters StreetEvents) |
04:30PM
|
|
11:55AM
|
|
08:05AM
|
|
07:33AM
|
|
07:03AM
|
(Associated Press Finance) |
06:55AM
|
|
Apr-29-24 04:30PM
|
|
Apr-24-24 11:00AM
|
|
09:40AM
|
|
Apr-23-24 10:01AM
|
|
Apr-22-24 06:00AM
|
|
Apr-18-24 12:10PM
|
|
Apr-17-24 06:00AM
|
|
Apr-15-24 06:00AM
|
|
Apr-10-24 10:00AM
|
(The Wall Street Journal) |
Apr-09-24 06:00AM
|
|
Apr-08-24 06:00AM
|
|
Apr-03-24 06:00AM
|
|
Apr-02-24 06:00AM
|
|
|
|
|
KBR, Inc. engages in the provision of science, technology, engineering, and logistics support solutions. It operates through the following segments: Government Solutions, Sustainable Technology Solutions, and Other. The Government Solutions segment involves the provision of research and development, advanced prototyping, acquisition support, systems engineering, C5ISR, cyber analytics, space domain awareness, test and evaluation, systems integration and program, global supply chain management, operations readiness and support, and professional advisory services. The Sustainable Technology Solutions segment combines proprietary technologies, equipment, and catalyst supply and associated knowledge-based services into a global business for refining, petrochemicals, inorganic, and specialty chemicals, gasification, syngas, ammonia, nitric acid, and fertilizers. The Other segment includes corporate expenses and selling, general and administrative expenses not allocated to the business segments above. The company was founded on March 21, 2006 and is headquartered in Houston, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ibrahim Jalal | Pres., Sustainable Tech Solns | Aug 19 '24 | Option Exercise | 18.30 | 22,190 | 406,077 | 141,550 | Aug 20 09:45 PM | Ibrahim Jalal | Pres., Sustainable Tech Solns | Aug 19 '24 | Sale | 66.56 | 35,000 | 2,329,488 | 106,550 | Aug 20 09:45 PM | JALAL IBRAHIM | Officer | Aug 19 '24 | Proposed Sale | 66.56 | 35,000 | 2,329,488 | | Aug 19 04:14 PM | GALINDO SONIA | EVP, Gen. Counsel & Corp. Sec. | May 20 '24 | Sale | 66.00 | 4,660 | 307,560 | 21,409 | May 21 07:13 PM | Myles Jennifer | EVP, Chief People Officer | Feb 22 '24 | Sale | 58.95 | 8,000 | 471,603 | 38,524 | Feb 26 07:58 PM |
|